Fig. 7From: Optimizing labelling conditions of 213Bi-DOTATATE for preclinical applications of peptide receptor targeted alpha therapySurvival (%) ± SD of CA20948 as function of concentration of ascorbic acid in DMEM incubation medium containing 30 mmol.L-1 HEPES and 0.25 % BSA (total volume was 8.4 mL), n = 3Back to article page